Sulfasalazine for brain cancer fits

Harald Sontheimer, Richard J Bridges, Harald Sontheimer, Richard J Bridges

Abstract

Recent research has identified an important role for a cystine-glutamate antiporter (system Xc) in the biology of malignant brain tumors. This transporter is effectively inhibited by sulfasalazine, a drug widely used to treat a number of chronic inflammatory conditions such as Crohn's disease. Preclinical data show that sulfasalazine is an effective inhibitor of tumor growth and tumor-associated seizures. These studies suggest that the cystine-glutamate antiporter is a valuable drug target for which tumor-specific drugs can be generated. In the meantime, sulfasalazine may be considered as adjuvant treatment for malignant gliomas.

Conflict of interest statement

Declaration of interest

The authors state no conflict of interest.

Figures

Figure 1. Homology model of xCT with…
Figure 1. Homology model of xCT with docked ligands
The model was established using the crystal structure coordinates of the amino acid, polyamine and organocation transporter (ApcT) from the RCSB protein databank (3GIA). Protein sequences of human xCT and ApcT were aligned using ClustalW after which the sequences were threaded and the pictured homology model of xCT generated using the default automodel process of MODELLER v9.9. Left shows the xCT model with glutamate docked, right shows it with sulfasalazine docked. The ligand (hot pink) structures were energy minimized using Tripos Sybyl (MMFF forcefield) and docked into the xCT homology model using CCDC GOLD and default settings (GoldScore) system. Modeling was carried out in the University of Montana Molecular Computational Core Facility, in collaboration with S. Patel, N. Natale, M. Braden and J. Gerdes. TMDs 2, 4, 6, 9, 11 and 12 of xCT have either been removed or colored light grey to permit a better view of ligand docking. TMDs shown in color include TMI (light pink), TM3 (dark blue), TM5 (teal), TM7 (olive), TM8 (bright green) and TM10 (gold). Note that only xCT is shown, as it is the subunit responsible for substrate transport. CD98, the regulatory subunit is required for membrane association and is not illustrated.

Source: PubMed

3
Suscribir